Eucomed Touts Uniqueness Of Tissue Products In Response To EU Reg

Eucomed stresses the differences between human tissue-engineered products (hTEPs) and pharmaceutical products in its June 29 response to a proposed advanced therapy regulation

More from Archive

More from Medtech Insight